Copyright
©The Author(s) 2021.
World J Gastrointest Pharmacol Ther. May 5, 2021; 12(3): 40-55
Published online May 5, 2021. doi: 10.4292/wjgpt.v12.i3.40
Published online May 5, 2021. doi: 10.4292/wjgpt.v12.i3.40
Criteria applied for liver injury definition | Ref. | Condition |
Elevated ALT | Tovo et al[47], 2006 | HIV/HCV |
ALT > 2 × ULN | Monteiro et al[25], 2012 | TB |
ALT > 2.5 × ULN | Zaverucha-do-Valle et al[41], 2014; Kondo et al[49], 2008 | TB/smoker; HIV |
ALT > 3 × ULN | Fernandes et al[68], 2015; Santos et al[53] 2013; | TB; TB |
ALT or AST > 2 × ULN | Alves et al[59], 2011; de Castro et al[44], 2010 | AR; TB/HBV |
ALT or AST > 3 × ULN | Heinrich[24], 2014; Vieira et al[78], 2008; Uehara et al[76] 2005 | TB/ indigenous; TB; IMQ |
ALT or AST > 3 × or BT > 1.5 × | Schultz et al[46], 2014 | TB/TX |
ALT > 3 × ULN; BT > 2 × | Brito et al[64], 2014; Nader et al[45], 2010 | TB/HCV |
ALT or AST > 3 × ULN; BT > 2 × | Lima Mde et al[65], 2012; Picon et al[66], 2002 | TB/HIV; TB |
ALT ≥ 5 × LSN ou FA ≥ 2 × LSN ou ALT ≥ 3 × ULN e BT ≥ 2 × LSN | Prado et al[27], 2019 | Gastro-hepatology conditions |
(1) ALT > 3 × lower limit of normality; (2) ALT > 3 × ULN; (3) ALT > 3 × ULN and BT > 2 × ULN | Coca et al[73], 2010 | TB/HIV |
ALT or AST: (1) 1.25 a 2.5 × ULN; (2) 2.6 a 5 × ULN; (3) 5.1 a 10 × ULN; (4) > 10 × ULN | Antonello et al[55], 2014 | HIV |
ALT or AST: (1) 1.25 a 2.5 × ULN; (2) 2.6 a 5 × ULN; (3) 5.1 a 10 × ULN; (4) > 10 × ULN or BT – (1) 1.1 a 1.5 × ULN; (2) 1.6 a 2.5 × ULN; (3) 2.6 a 5.0 × ULN; (4) > 5.0 × ULN | Tomich et al[77], 2015 | TB/HIV |
Altered ALT or AST (hepatotoxicity) and ALT or AST > 5 × (hepatitis) | Gusmão Filho et al[43], 2001 | TB/children |
ALT or AST > 3 × ULN and hepatitis syndromes | Teixeira et al[52], 2011 | TB |
AST > 3 × ULN and hepatitis syndromes | Szklo et al[67], 2007 | TB/previous liver injury |
Altered ALT, AST, AP or BT | de Souza et al[79], 1996 | TB |
Increase in liver function tests | de-Medeiros et al[75], 1998 | LMA |
Histological assessments | Santos[63], 2013 | QT/HPTC |
AST or ALT: (1) 1.1-4.9 × ULN; (2) 5.0-9.9 × ULN; (3) 10.0-15.0 × ULN; (4) > 15.0 × ULN | Gil et al[48], 2007 | HIV/child/adolescent |
ALT > 2 times ULN or the ALT/AP ratio ≥ 5 or AP > 2 times ULN ALT/AP ratio ≤ 2 or ALT > 2 times ULN and ALT/AP ratio between 2 and 5 | Magalhães[26], 2015 | Several |
ALT ou AST > 2 × LSN e BT > 1.3 mg/dL | Santos et al[23], 2019 | TB |
NI | Silva et al[22], 2019; Carvalho et al[74], 2014; Werner et al[61], 1989 | IBD; Ulcerative colitis; Grave’s disease |
- Citation: Becker MW, Schwambach KH, Lunardelli M, Blatt CR. Overview of drug induced liver injury in Brazil: What is the role of public health policy on the evidence? World J Gastrointest Pharmacol Ther 2021; 12(3): 40-55
- URL: https://www.wjgnet.com/2150-5349/full/v12/i3/40.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v12.i3.40